Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic - Fleischhacker,W.W.; Eerdekens,M.; Karcher,K.; Remington,G.; Llorca,P.M.; Chrzanowski,W.; Martin,S.; Gefvert,O. (J Clin Psychiatry, 2003)